RCKT Return on Tangible Equity | Rocket Pharmaceuticals, Inc.

Rocket Pharmaceuticals, Inc. (RCKT) Return on Tangible Equity

2026-06-30: Return Tang Equity -5.66%.
2026-03-31: Return Tang Equity -120.52%.
2025-12-31: Return Tang Equity -104.79%.
2025-09-30: Return Tang Equity -96.61%.

Complete source-backed return tang equity history.

Available history: 2014-12-31 to 2026-06-30
Data captured: 2026-09-04

Historical Return Tang Equity

Date	Return Tang Equity
2026-06-30	-5.66%
2026-03-31	-120.52%
2025-12-31	-104.79%
2025-09-30	-96.61%
2025-06-30	-88.75%
2025-03-31	-74.18%
2024-12-31	-64.86%
2024-09-30	-97.22%
2024-06-30	-79.06%
2024-03-31	-66.10%
2023-12-31	-57.35%
2023-09-30	-52.99%
2023-06-30	-73.51%
2023-03-31	-60.21%
2022-12-31	-52.23%
2022-09-30	-59.25%
2022-06-30	-53.73%
2022-03-31	-44.43%
2021-12-31	-39.88%
2021-09-30	-40.84%
2021-06-30	-35.91%
2021-03-31	-34.55%
2020-12-31	-29.55%
2020-09-30	-46.74%
2020-06-30	-37.69%
2020-03-31	-32.32%
2019-12-31	-27.95%
2019-09-30	-42.13%
2019-06-30	-37.46%
2019-03-31	-53.76%
2018-12-31	-45.65%
2018-09-30	-47.74%
2018-06-30	-35.23%
2018-03-31	-23.00%
2017-12-31	-124.91%
2017-09-30	18.75%
2017-06-30	8.99%
2017-03-31	-0.29%
2016-12-31	-90.47%
2016-09-30	-44.74%
2016-06-30	-86.84%
2016-03-31	-77.17%
2015-12-31	-437.46%
2015-09-30	-53.19%
2015-06-30	-26.44%
2015-03-31	-26.05%
2014-12-31	18.49%

Annual Return Tang Equity

Date	Return Tang Equity
2025-12-31	-104.79%
2024-12-31	-64.86%
2023-12-31	-57.35%
2022-12-31	-52.23%
2021-12-31	-39.88%
2020-12-31	-29.55%
2019-12-31	-27.95%
2018-12-31	-45.65%
2017-12-31	-126.16%
2016-12-31	-90.47%
2015-12-31	-437.46%
2014-12-31	18.49%

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
STANDARD BIOTOOLS INC. (LAB)	United States	$0.297B	3.80
Vanda Pharmaceuticals Inc. (VNDA)	United States	$0.302B	-1.35
Fulcrum Therapeutics, Inc. (FULC)	United States	$0.289B	-3.28
Contineum Therapeutics, Inc. (CTNM)	United States	$0.289B	-4.40
Perspective Therapeutics, Inc. (CATX)	United States	$0.284B	-3.34
Upstream Bio, Inc. (UPB)	United States	$0.284B	-2.42
GT Biopharma, Inc. (GTBP)	United States	$0.309B	-4.58
ABEONA THERAPEUTICS INC. (ABEO)	United States	$0.312B	-5.63
Sagimet Biosciences Inc. (SGMT)	United States	$0.279B
Prelude Therapeutics Inc (PRLD)	United States	$0.318B	-7.01